National Clinical Trials

 

CURRENT STUDIES


National Ophthalmic Genotyping Network (eyeGENE)


Age Related Eye Disease Study II (AREDS II)


Lucentis plus Sirolimus for AMD (EMERALD)


Lucentis plus Volociximab for AMD (OPTHOTECH)


High Dose Lucentis for AMD (HARBOR)


Lucentis for Retinal Vein Occlusion (HORIZON)


Lucentis vs Avastin for AMD (CATT)


Lucentis for Diabetic Macular Edema (RISE)


Lucentis to Prevent PRP-Induced Retinal Edema (PRIME)


Microplasmin for non-surgical treatment of Vitreomacular Traction Syndrome (Thrombogenics)



COMPLETED STUDIES


Lucentis for Branch Retinal Vein Occlusion (BRAVO)


Lucentis for Central Retinal Vein Occlusion (CRUISE)


Lucentis for AMD for Patients Previously Enrolled in MARINA/FOCUS Trials (HORIZON)


Diabetic Retinopathy Clinical Research Trial: IVT vs. Grid Laser (DRCR)


Standard Care vs. Corticosteroid for Retinal Vein Occlusion Study (SCORE)


Lucentis for AMD (SAILOR)


Lucentis/Visudyne (DENALI)


Phase I/II Study of Lucetis/Visudyne for AMD (FOCUS)


Phase III Study of Lucentis for AMD (MARINA)


Visudyne/IVT vs. Visudyne/Macugen for AMD (VERITAS)


Visudyne for Minimally Classic AMD (VMC)


VIT-100


ASPEN Study for Non-insulin Dependant DM


TTT4CNV


Complications of Age Related Macular Degeneration Trial Prevention Trial (CAPT)


CNVPT Pilot Study


Submacular Surgery Trial (SST)


MBBK; MBBM


Radiation Treatment For AMD


Interferon for AMD


Collaborative Ocular Melanoma Study (COMS)